[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100614603":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":21,"locations":32,"responsibleParty":52,"collaborators":20,"id":54,"slug":55,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":58,"acronym":20,"eligibilityCriteria":59,"healthyVolunteers":60,"sex":61,"minAge":62,"maxAge":63,"enrollmentInfo":64,"targetDuration":20,"studyType":67,"phases":68,"briefSummary":70,"conditions":71,"keywords":73,"overallStatus":34,"whyStopped":20,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"Retina Foundation of the Southwest","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Treatment with Curesight videos","EXPERIMENTAL","with this IRB application), indicated for improvement in visual acuity and stereo acuity in amblyopia patients, aged 4 - \\\u003C9 years, associated with anisometropia and\u002For with mild strabismus. This approval was based on data from a pilot study and a multi-center randomized clinical trial conducted with children aged 4 to 8 years.25,26 However, very few children older than age 7 years were included so the effectiveness of Curesight™ treatment for children aged 8 to 12 is unknown. Our pilot study will evaluate response to the Curesight™ treatment in this older age range.",[13],"Device: Curesight dichoptic videos",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","Curesight dichoptic videos","Streamed videos are converted into 2 anaglyph channels, blue images for the amblyopic eye and red images for the fellow eye, and are presented superimposed. The stronger eye has blur imposed in the central visual area; the weaker amblyopic eye channel is not affected by the blur.",[9],null,[22,27],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},"Eileen E Birch, PhD","CONTACT","12144771464","ebirch@retinafoundation.org",{"name":28,"role":24,"phone":29,"phoneExt":30,"email":31},"Reed M Jost, MS","2143633911","113","reedjost@retinafoundation.org",[33],{"facility":5,"status":34,"city":35,"state":36,"zip":37,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"RECRUITING","Dallas","Texas","75231","United States","US",{"type":41,"coordinates":42},"Point",[43,44],-96.80667,32.78306,{"lat":44,"lon":43},[47,51],{"name":48,"role":24,"phone":49,"phoneExt":20,"email":50},"Eileen CEO","214-363-3911","kcsaky@retinafoundation.org",{"name":28,"role":24,"phone":29,"phoneExt":30,"email":31},{"type":53,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100614603","amblyopia-treatment-for-children-aged-8-to-12-years-100614603",false,"NCT07281742","Amblyopia Treatment for Children Aged 8 to 12 Years","Inclusion Criteria:\n\n* Female and male children with amblyopia age 8-12 years inclusive\n* Amblyopic eye visual acuity ≤ 1.0 logMar (20\u002F32-20\u002F200)\n* Interocular difference in visual acuity of 0.3 logMAR or more\n* Anisometropia or strabismus corrected to \\\u003C5 pd\n* Wearing glasses (if needed) ≥8 weeks\n* No longer using standard-of-care treatments for amblyopia\n* Informed consent\n\nExclusion Criteria:\n\n* Prematurity \\>8 weeks\n* Coexisting ocular or systemic disease\n* Developmental delay\n* History of light-induced epilepsy\n* Eye conditions that interfere with eye tracking (nystagmus, wearing RGP contact lenses, paralysis of the extra ocular muscles or any neurological condition that restricts eye movements, ptosis that covers the pupil)",true,"ALL","8 Years","12 Years",{"count":65,"type":66},30,"ESTIMATED","INTERVENTIONAL",[69],"NA","This study is being done to assess the effect of at-home amblyopia treatment with Curesight™ for children aged 8 to 12 years. Curesight™ allows you to stream any videos on a computer screen at home but the amblyopic eye will see the entire screen clearly while part of the image will be blurred for the other eye. There is already a pivotal clinical trial showing that this treatment is effective for young children and Curesight™ has been cleared for use as an amblyopia treatment by the FDA for children as young as 4 years.",[72],"Amblyopia",[74,75,76],"amblyopia","dichoptic","children","2025-12-04",{"date":79,"type":80},"2025-12-15","ACTUAL",{"date":82,"type":80},"2025-01-07",{"date":84,"type":66},"2028-06-30",{"name":5,"class":6},1]